The Two Process model of homeostatic sleep regulation posits that the timing of sleep results from an interaction between a circadian process (Process C) and a homeostatically regulated sleep process (Process S). Process C is linked to neural systems that generate circadian rhythms, but the neural basis of Process S is currently unknown. During the previous funding period, we identified a population of GABAergic cells in the cerebral cortex that express neuronal nitric oxide synthase (nNOS) and also express the transcription factor FOS specifically during sleep and after sleep deprivation (SD). Activation of nNOS neurons is negatively correlated with time awake, unrelated to REM sleep, and most closely linked to NREM bout duration and NREM delta energy. In the absence of nNOS, mice have altered slow wave activity (SWA) during both wakefulness and sleep, are unable to sustain long bouts of NREM sleep, and are unable to respond to a homeostatic sleep challenge despite being sleepier than wild type (WT) mice. Based on these results, we hypothesize that cortical nNOS neurons are involved in the homeostatic regulation of sleep and are a neuroanatomical substrate of Process S. To test this hypothesis, we will first ask whether these sleep-active cortical nNOS neurons are projection neurons and use state-of-the-art viral tracers to identify afferents to these neurons. To determine the role of different afferent inputs in regulating corticl nNOS neurons, we will conduct in vitro patch clamp electrophysiology recordings to determine which neurotransmitters and neuromodulators previously implicated in the control of sleep and wakefulness excite or inhibit sleep-active cortical nNOS cells. We will address whether cortical nNOS neurons are causally involved in sleep homeostasis using optogenetic and pharmacogenetic approaches to activate these cells and characterize the effects on sleep/wake architecture and EEG spectra. Lastly, we will assess the role of nitric oxide derived from cortical nNOS neurons in sleep homeostasis by optogenetic and pharmacogenetic stimulation in the presence and absence of nitric oxide inhibitors. These experiments will elucidate the neurobiology of cortical nNOS neurons and allow us to determine whether the activity of cortical sleep-active nNOS cells is indeed related to Process S. The results will not only enhance our understanding of sleep/wake regulation, but may also have implications for understanding the role of sleep in neurological and psychiatric diseases involving the cortex such as epilepsy, anxiety, and schizophrenia.
This proposal is intended to extend our understanding of the neural circuitry and function of a rare population of cells in the cerebral cortex that are activatd during sleep. These GABAergic interneurons express the enzyme neuronal nitric oxide synthase (nNOS) and are the first phenotypically-defined cortical neuron population known to be active during sleep. Using a recently created transgenic mouse that conditionally expresses a reporter for nNOS, we will identify the afferent inputs to these sleep active cells and determine whether these neurons project widely in the cortex. We will also identify the neurotransmitters and neuromodulators that activate or inhibit nNOS neurons and which may therefore activate these cells during sleep and inhibit them during wakefulness. Lastly, we will assess the effects of selective activation of these cells on brain physiology in the presence and absence of nitric oxide inhibitors. The results will not only enhance our understanding of sleep/wake regulation, but may also have implications for understanding sleep disorders and neurological and psychiatric diseases involving the cerebral cortex such as epilepsy, anxiety, and schizophrenia.
|Dittrich, Lars; Morairty, Stephen R; Warrier, Deepti R et al. (2015) Homeostatic sleep pressure is the primary factor for activation of cortical nNOS/NK1 neurons. Neuropsychopharmacology 40:632-9|
|Sunkin, Susan M; Ng, Lydia; Lau, Chris et al. (2013) Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Res 41:D996-D1008|
|Wisor, Jonathan P; Gerashchenko, Dmitry; Kilduff, Thomas S (2011) Sleep-active neuronal nitric oxide synthase-positive cells of the cerebral cortex: a local regulator of sleep? Curr Top Med Chem 11:2483-9|
|Kilduff, Thomas S; Cauli, Bruno; Gerashchenko, Dmitry (2011) Activation of cortical interneurons during sleep: an anatomical link to homeostatic sleep regulation? Trends Neurosci 34:10-9|
|Gerashchenko, Dmitry; Wisor, Jonathan P; Kilduff, Thomas S (2011) Sleep-active cells in the cerebral cortex and their role in slow-wave activity. Sleep Biol Rhythms 9:71-77|
|Hirashima, Noriko; Tsunematsu, Tomomi; Ichiki, Kanako et al. (2011) Neuropeptide B induces slow wave sleep in mice. Sleep 34:31-7|
|Pasumarthi, R K; Gerashchenko, D; Kilduff, T S (2010) Further characterization of sleep-active neuronal nitric oxide synthase neurons in the mouse brain. Neuroscience 169:149-57|
|Kilduff, Thomas S; Lein, Ed S; de la Iglesia, Horacio et al. (2008) New developments in sleep research: molecular genetics, gene expression, and systems neurobiology. J Neurosci 28:11814-8|
|Gerashchenko, Dmitry; Wisor, Jonathan P; Burns, Deirdre et al. (2008) Identification of a population of sleep-active cerebral cortex neurons. Proc Natl Acad Sci U S A 105:10227-32|
|Wisor, Jonathan P; Pasumarthi, Ravi K; Gerashchenko, Dmitry et al. (2008) Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains. J Neurosci 28:7193-201|
Showing the most recent 10 out of 28 publications